Keyphrases
Oridonin
100%
NLRP3 Inhibitors
100%
Anti-inflammasome
100%
NOD-like Receptor Protein 3 (NLRP3)
62%
NLRP3 Inflammasome
37%
Anti-inflammatory Activity
25%
Mouse Model
12%
Specific Inhibitor
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Human Disease
12%
Chronic Inflammation
12%
New Therapeutics
12%
Cysteine
12%
Therapeutic Effect
12%
Inflammasome Activation
12%
Direct Target
12%
Peritonitis
12%
Covalent Bond
12%
Active Ingredients
12%
Covalent Inhibitor
12%
NACHT Domain
12%
Preventive Effect
12%
NLRP3 Activation
12%
Inflammasome Assembly
12%
Gouty Arthritis
12%
Chinese Medicinal Herbs
12%
NEK7
12%
Rabdosia Rubescens
12%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammasome
100%
Oridonin
100%
Anti-Inflammatory Drug
25%
Diseases
25%
Mouse Model
12%
Cysteine
12%
Therapeutic Effect
12%
Gout
12%
Chronic Inflammation
12%
Peritonitis
12%
Covalent Bond
12%
Isodon rubescens
12%
Maturity Onset Diabetes of the Young
12%
Immunology and Microbiology
Inflammasome
100%
NLRP3
100%
NLRP3 Inflammasome
42%
Antiinflammatory Activity
28%
Mouse Model
14%
Gout
14%
Peritonitis
14%
Covalent Bond
14%
Cysteine
14%
Isodon rubescens
14%